BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28697547)

  • 21. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
    Lasoń E; Sikora E; Ogonowski J
    Acta Biochim Pol; 2013; 60(4):773-7. PubMed ID: 24432330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of high pressure homogenization conditions to produce nanostructured lipid carriers using natural and synthetic emulsifiers.
    Luisa Lüdtke F; Aparecida Stahl M; Grimaldi R; Bruno Soares Forte M; Lúcia Gigante M; Paula Badan Ribeiro A
    Food Res Int; 2022 Oct; 160():111746. PubMed ID: 36076468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
    Kovács A; Berkó S; Csányi E; Csóka I
    Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
    Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
    J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of surfactant on lycopene-loaded nanostructured lipid carriers.
    Riangjanapatee P; Okonogi S
    Drug Discov Ther; 2012 Jun; 6(3):163-8. PubMed ID: 22890207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations.
    Yang X; Zhao L; Almasy L; Garamus VM; Zou A; Willumeit R; Fan S
    Int J Pharm; 2013 Jun; 450(1-2):225-34. PubMed ID: 23608200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical Properties of Defatted Rambutan (Nephelium lappaceum) Seed Flour after Alkaline Treatment.
    Eiamwat J; Wanlapa S; Kampruengdet S
    Molecules; 2016 Mar; 21(4):364. PubMed ID: 27043520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rambutan (
    Wanthong T; Klinkesorn U
    J Food Sci Technol; 2020 Dec; 57(12):4404-4413. PubMed ID: 33087954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.
    Wang J; Tang J; Zhou X; Xia Q
    Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
    Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic.
    Lin T; Huang X; Wang Y; Zhu T; Luo Q; Wang X; Zhou K; Cheng H; Peng D; Chen W
    Xenobiotica; 2017 Sep; 47(9):793-799. PubMed ID: 27618478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic medium.
    Souto EB; Gohla SH; Müller RH
    Pharmazie; 2005 Sep; 60(9):671-3. PubMed ID: 16222866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection and viability of fruit seeds oils by nanostructured lipid carrier (NLC) nanosuspensions.
    Krasodomska O; Paolicelli P; Cesa S; Casadei MA; Jungnickel C
    J Colloid Interface Sci; 2016 Oct; 479():25-33. PubMed ID: 27348480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fat properties and antinutrient content of rambutan (Nephelium lappaceum L.) seed during solid-state fermentation of rambutan fruit.
    Chai KF; Adzahan NM; Karim R; Rukayadi Y; Ghazali HM
    Food Chem; 2019 Feb; 274():808-815. PubMed ID: 30373014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.
    Selvaraj K; Yoo BK
    AAPS PharmSciTech; 2019 Jul; 20(6):252. PubMed ID: 31300965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.